GLITARIS M15

Glitaris M 15 Tablet is a medication designed to assist in managing blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This formulation works in conjunction with dietary modifications and physical activity to enhance glycemic control among adult patients. The active components promote effective insulin utilization, thereby contributing to a reduction in blood sugar concentrations. It is essential for patients to adhere to the prescribed dosage and treatment duration as directed by their healthcare provider. This medication should be ingested during meals to minimize the risk of gastrointestinal discomfort. If a dose is overlooked, it should be taken promptly unless it is near the time of the subsequent dose; in that case, the missed dose should be skipped, and normal dosing should resume without doubling up. It is critical to avoid overdose as it can result in hypoglycemia, which is characterized by dangerously low blood sugar levels. While some individuals may experience mild and generally non-severe side effects such as nausea, change in appetite, alterations in taste, abdominal discomfort, diarrhea, and swelling, these effects typically resolve on their own. If any side effects persist or become concerning, patients are encouraged to consult their healthcare provider for guidance. Prior to initiating treatment with Glitaris M 15 Tablet, it is crucial to inform the prescribing physician of any existing kidney, liver, or heart conditions. Pregnant or nursing individuals should seek medical advice before using this medication. Routine kidney function tests may be conducted to ensure safe use.